0001209191-20-032445.txt : 20200527
0001209191-20-032445.hdr.sgml : 20200527
20200527195451
ACCESSION NUMBER: 0001209191-20-032445
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200522
FILED AS OF DATE: 20200527
DATE AS OF CHANGE: 20200527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kroll Werner
CENTRAL INDEX KEY: 0001609320
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 20916675
MAIL ADDRESS:
STREET 1: 12544 HIGH BLUFF DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-22
0
0000353569
QUIDEL CORP /DE/
QDEL
0001609320
Kroll Werner
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
0
1
0
0
SVP, R&D
Common Stock
2020-05-22
4
M
0
17596
23.41
A
22195
D
Common Stock
2020-05-22
4
M
0
35192
15.40
A
57387
D
Common Stock
2020-05-22
4
M
0
10758
21.08
A
68145
D
Common Stock
2020-05-22
4
M
0
4606
46.41
A
72751
D
Common Stock
2020-05-22
4
S
0
68152
174.4358
D
4599
D
Common Stock
2020-05-27
4
M
0
4376
0.00
A
8975
D
Common Stock
2020-05-27
4
F
0
2304
0.00
D
6671
D
Non-Qualified Stock Options
23.41
2020-05-22
4
M
0
17596
0.00
D
2025-02-05
Common Stock
17596
0
D
Non-Qualified Stock Options
15.40
2020-05-22
4
M
0
35192
0.00
D
2026-02-10
Common Stock
35192
0
D
Non-Qualified Stock Options
21.08
2020-05-22
4
M
0
10758
0.00
D
2027-02-15
Common Stock
10758
3585
D
Non-Qualified Stock Options
46.41
2020-05-22
4
M
0
4606
0.00
D
2028-01-16
Common Stock
4606
4606
D
Restricted Stock Units
2020-05-27
4
M
0
4376
0.00
D
Common Stock
4376
8752
D
The amount of securities beneficially owned following this transaction include an additional 272 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
The weighted average sale price for these transactions was $174.4358 per share, with a range of $171.69 to $180.50. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
Reflects release of restricted stock units that were previously reported on Form 4.
The disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon vesting of restricted stock units.
17,596 shares vested on 02/05/2017; 8,798 shares vested on 02/05/2018; and 8,798 shares vested on 02/05/2019.
17,596 shares vested on 02/10/2018; 8,798 shares vested on 02/10/2019; and 8,798 shares vested on 02/10/2020.
7,172 shares vested on 02/15/2019; 3,586 shares vested on 02/15/2020; and 3,585 shares will vest on 02/15/2021.
4,606 shares vested on 01/16/2020; 2,303 shares will vest on 01/16/2021; and 2,303 shares will vest on 01/16/2022.
Restricted stock units convert into common stock on a one-for-one basis.
On 05/27/2014, the Reporting Person was granted 17,505 restricted stock units vesting as follows: 4,377 shares vested on 05/27/2019; 4,376 shares vested on 05/27/2020; 4,376 shares will vest on 05/27/2021; and 4,376 shares will vest on 05/27/2022.
All transactions occurring on May 22, 2020 were effected pursuant to a pre-established 10b5-1 trading plan
Robert J. Bujarski, attorney-in-fact for Werner Kroll
2020-05-27